RecruitingNCT07131293

European Registry Study on Lymphatic Interventions

European Registry Study on Lymphatic Interventions: Towards Standardized Care in CHD-Related Lymphatic Disorders


Sponsor

Rigshospitalet, Denmark

Enrollment

500 participants

Start Date

Feb 1, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

This European multicenter observational study aims to evaluate the real-world use, timing, and outcomes of lymphatic interventions in patients with congenital heart disease and/or primary lymphatic disorders. The study will examine the effectiveness of diagnostic imaging and interventional techniques, such as lymphatic embolization, in improving clinical symptoms, biomarkers, and fluid-related complications. The central question is whether early diagnosis and targeted intervention can lead to clinically meaningful improvements and reduced need for reintervention. Data collected retrospectively and prospectively from participating centers will help identify predictors of outcome, assess disease severity, and inform standardized diagnostic and therapeutic pathways across Europe.


Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Lymphatic intervention for people with chylothorax, lymphatic abnormalities, and other related conditions. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURELymphatic intervention

This intervention was made as part of their clinical treatment.


Locations(1)

Rigshospitalet, Copenhagen University Hospital

Copenhagen, Denmark

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07131293


Related Trials